AXT Inc
AXTI
$0.00
+12.09%
AXT Inc is a developer and producer of compound and single-element semiconductor substrates, also known as wafers. It is a specialized materials supplier in the semiconductor industry, focusing on high-performance alternative substrates for advanced electronic circuits.
AXTI
AXT Inc
$0.00
Related headlines
Investment Opinion: Should I buy AXTI Today?
Based on a synthesis of the parabolic price move, deteriorating fundamentals, extreme valuation, and cautious analyst actions (downgrades to Hold/Neutral), the objective assessment of the data points to a Sell rating for new capital. The current price appears to have far outpaced the company's near-term financial reality, creating a highly asymmetric risk/reward profile skewed to the downside unless the anticipated AI-driven revenue surge is both immediate and massively profitable.
Sign up to view all
AXTI 12-Month Price Forecast
The AI assessment is bearish due to a severe disconnect between speculative price action and weak underlying financials. While the long-term thematic is valid, the probability of the stock sustaining its current valuation over the next 12 months without immediate, dramatic fundamental improvement is low.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on AXT Inc's 12-month outlook, with a consensus price target around $0.00 and implied upside of — versus the current price.
Average Target
$0.00
2 analysts
Implied Upside
—
vs. current price
Analyst Count
2
covering this stock
Price Range
$0 - $0
Analyst target range
Wall Street analyst coverage for AXT Inc is limited, with only two analysts providing estimates. The consensus estimated EPS for the upcoming period is $0.4875, with a range from $0.195 to $0.77114. Estimated average revenue is $172.68 million. Recent institutional rating actions show a shift towards caution; Needham downgraded from 'Buy' to 'Hold' in January 2026, and B. Riley Securities downgraded from 'Buy' to 'Neutral' the same month, though Wedbush maintains an 'Outperform' rating. The limited number of analysts suggests coverage is sparse.
Bulls vs Bears: AXTI Investment Factors
AXTI presents a classic high-risk, high-reward investment case. The stock's monumental rally is fueled by its strategic positioning in AI-enabling semiconductor materials, but this optimism starkly contrasts with current weak financials, declining revenue, and persistent losses. The investment thesis hinges entirely on the company's ability to rapidly convert future AI-driven demand into profitable growth.
Bullish
- Parabolic Price Momentum: Stock up over 1112% in 6 months, driven by AI substrate demand.
- Strong Balance Sheet: Low debt-to-equity (0.24) and high current ratio (2.72) provide stability.
- Gross Margin Recovery: Q4 gross margin improved to 20.95% from negative earlier in 2025.
- High Analyst Growth Estimates: Consensus EPS forecast of $0.49 implies a sharp turnaround.
Bearish
- Extreme Valuation: PS ratio of 8.13 and forward P/E of 122.1 are exceptionally high.
- Persistent Unprofitability: Negative ROE (-7.78%), ROA (-3.55%), and net income in Q4.
- Revenue Decline: Q4 revenue fell 8.2% YoY, showing weak near-term fundamentals.
- Heavy Cash Burn: TTM free cash flow is -$18.78M, raising sustainability concerns.
AXTI Technical Analysis
The stock has exhibited an exceptionally strong overall uptrend over the past six months, with the price rising from $4.70 on October 2, 2025, to $56.98 by March 31, 2026, representing a gain of over 1112%. This surge has been driven by significant momentum, particularly in recent months. Short-term performance has been extremely volatile but positive, with the stock up 50.34% over the past month and 248.50% over the past three months, far outpacing the broader market's negative returns. The current price of $56.98 is near the upper end of its 52-week range of $1.13 to $71.49, sitting approximately 80% above the low and 20% below the recent high, indicating the stock is in a strong uptrend but may be consolidating after a parabolic rise.
Beta
1.51
1.51x market volatility
Max Drawdown
-37.0%
Largest decline past year
52-Week Range
$1-$71
Price range past year
Annual Return
+3353.6%
Cumulative gain past year
| Period | AXTI Return | S&P 500 |
|---|---|---|
| 1m | +26.5% | -4.3% |
| 3m | +215.3% | -4.0% |
| 6m | +930.0% | -2.0% |
| 1y | +3353.6% | +22.2% |
| ytd | +215.3% | -3.8% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
AXTI Fundamental Analysis
Revenue and profitability trends show a challenging picture. Q4 2025 revenue was $23.04 million, down 8.22% year-over-year, and the company reported a net loss of $3.55 million with a net margin of -15.4%. The gross margin improved to 20.95% in Q4 from negative levels earlier in the year, but operating and net margins remain negative. Financial health appears mixed; the company has a low debt-to-equity ratio of 0.24 and a strong current ratio of 2.72, indicating good short-term liquidity. However, free cash flow over the trailing twelve months is deeply negative at -$18.78 million, and operating cash flow has been inconsistent, raising concerns about cash burn. Operational efficiency metrics are weak, with a negative Return on Equity (ROE) of -7.78% and a negative Return on Assets (ROA) of -3.55%, reflecting poor profitability relative to shareholder equity and total assets.
Quarterly Revenue
$23041000.0B
2025-12
Revenue YoY Growth
-0.08%
YoY Comparison
Gross Margin
+0.20%
Latest Quarter
Free Cash Flow
$-18778000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is AXTI Overvalued?
Given the company's negative net income and EBITDA, the Price-to-Sales (PS) ratio is the most appropriate valuation metric. The current PS ratio is 8.13, which is elevated and reflects the market's high growth expectations, particularly around AI-driven demand for its substrates. For peer comparison, industry average valuation data is not available in the provided inputs, so a relative assessment cannot be made. The forward P/E of 122.10 is exceptionally high, further underscoring that the valuation is pricing in a significant future earnings recovery.
PE
-33.8x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range -52x~35x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
-32.3x
Enterprise Value Multiple
Investment Risk Disclosure
The primary risk is valuation dislocation. The stock's Price-to-Sales ratio of 8.13 and forward P/E of 122.1 price in a near-perfect execution of a multi-year growth story, leaving no room for error. Fundamental risks are severe: the company is burning cash (TTM FCF: -$18.78M), revenues are contracting (Q4 down 8.2% YoY), and profitability metrics (ROE: -7.78%) are deeply negative. Operational risks include the company's ability to scale production and secure long-term contracts in a competitive semiconductor materials market. Market risks are elevated, evidenced by the stock's high beta (1.81) and extreme volatility, with a 52-week range from $1.13 to $71.49. The recent news of a major investor (Pacific Ridge) fully exiting its position after the rally signals smart money profit-taking, adding to the sentiment risk that the speculative bubble may deflate if growth fails to materialize as quickly as priced in.
FAQ
The key risks are: 1) Valuation Collapse: The stock could correct sharply if growth disappoints. 2) Cash Burn: The company has negative free cash flow (-$18.78M TTM), threatening its financial stability. 3) Operational Failure: It must successfully scale production and win contracts to justify its price. 4) Market Volatility: With a beta of 1.81, the stock is highly sensitive to market downturns and sector rotation.
The 12-month outlook is highly uncertain. The base case (50% probability) sees the stock trading between $35 and $55 as it grapples with high expectations. The bear case (30% probability) could see a fall to $15-$30 if fundamentals worsen. The bull case (20% probability) could drive prices to $65-$85 if AI demand sparks a dramatic turnaround. The wide range reflects the stock's speculative nature.
AXTI stock is significantly overvalued based on traditional fundamental metrics. The company is unprofitable with negative ROE and ROA, yet trades at a PS ratio of 8.13. The forward P/E of 122.1 implies astronomical future earnings growth that is not yet visible in its financial statements. The valuation reflects speculative optimism about AI demand, not present-day business performance.
At its current price of $56.98, AXTI is not a good stock to buy for most investors. The valuation is extreme, with a Price-to-Sales ratio of 8.13 and a forward P/E of 122, which demands near-perfect future execution. This contrasts sharply with recent financials showing an 8.2% revenue decline and a net loss in Q4 2025. The risk of a significant pullback is high if growth does not materialize immediately.
AXTI is not suitable for traditional long-term investment due to its lack of profitability and cash flow. It is a highly speculative, thematic trade on AI materials demand, which aligns more with a short-to-medium term horizon for risk-tolerant traders. Long-term investors should wait for evidence of sustainable competitive advantages and consistent financial improvement before considering a position.